XML 26 R15.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
We operate in one operating segment that is focused on the discovery, development, and commercialization of innovative vaccines. Our Chief Executive Officer is the Chief Operating Decision Maker (“CODM”). The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The following table presents segment revenue, measures of our segment’s profit or loss, and significant segment expenses (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
Total revenues$95,442 $73,795 $163,606 $124,584 
Less (add) (1):
Cost of sales - product14,035 11,985 27,804 22,952 
Research and development16,619 14,950 35,996 28,478 
Selling and marketing23,838 24,359 48,408 49,799 
General and administrative26,521 17,303 49,629 35,928 
Other segment items (2)
(4,292)(6,188)79,147 (15,238)
Segment income (loss) (3)
$18,721 $11,386 $(77,378)$2,665 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Other segment items includes the net of: bad debt expense, interest income, interest expense, sublease income, loss on debt extinguishment, other expenses, and provision for income taxes, as presented on the face of our condensed consolidated statements of operations.
(3)Net income (loss) is our reported measure of segment profit or loss.